Cancers & Diseases

When you're in the middle of cancer treatment, it can feel like your oncology team has become your entire medical world. Infusion days, lab draws, follow-up scans: your calendar fills up fast, and everything else starts to feel like it can wait.But here's something your care team at The Center for Cancer and Blood Disorders wants you to hear: routine healthcare doesn't stop mattering just because cancer treatment has started. In fact, in some ways it matters more.Your oncologist is focused on fighting your cancer. Your primary care physician, your dentist, and the specialists managing your other health conditions are focused on the rest of you. When those relationships go quiet during treatment, gaps can open up: and small things that would have been easy to catch become harder to manage.Your whole health matters to us, not just your oncology care. And keeping your broader healthcare routine in place is one of the most important things you can do to support your treatment and your recovery.

The start of a new school year is a season of fresh beginnings, new classrooms, new schedules, and new rhythms. For families navigating cancer treatment, it can also bring a unique layer of complexity. Balancing school drop-offs, homework, and extracurriculars alongside chemotherapy appointments, lab draws, and follow-up visits takes planning, flexibility, and support.The good news: with a little preparation, your family can find a rhythm that keeps treatment on track and makes room for the everyday moments that matter most.

Flatiron Health and Community Oncology Alliance partner to deliver first comprehensive, real-world assessment of care in community oncology, affirming the high-quality care delivered across community practices.Patients diagnosed with metastatic breast cancer and non-small cell lung cancer had longer survival compared to national benchmarks when treated in independent community oncology practices, according to a new study commissioned by the Community Oncology Alliance (COA) and conducted by Flatiron Health. The research supports independent community oncologists' ability to deliver high-quality outcomes for the majority of U.S. patients with cancer who receive care in community oncology settings.The study shows that median survival for patients diagnosed with breast cancer that spread to other organs and treated at a Flatiron Health Research Network (FHRN) community oncology practice exceeded national benchmarks by eight months. Median survival for those with non-small cell lung cancer- the most common lung cancer- treated at FHRN community oncology practices exceeded national benchmarks by two month. Survival rates after one, three, and five years were consistently higher for patients treated at community oncology practices within the FHRN relative to national benchmarks.Click to read the full press releaseClick to read the full study on quality of care in community oncology